Status | Study |
Active, not recruiting |
Study Name: Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Condition: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Polyra Date: 2014-01-03 Interventions: Biological: IgPro20 |
Completed |
Study Name: MRI in Diagnosing and Monitoring CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2013-12-06 |
Completed |
Study Name: Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2013-04-01 Interventions: Drug: NPB-01 Other Name: Intravenous immunoglobulin |
Withdrawn |
Study Name: Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD) Condition: Chronic Inflammatory Demyelinating Neuropathy Date: 2012-12-06 Interventions: Drug: Alemtuzumab infusion |
Completed |
Study Name: Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2012-06-19 Interventions: Drug: Fingolimod Drug: Placebo Comparator |
Completed |
Study Name: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) Condition: Chronic Inflammatory Demyelinating Polyneuropathy Polyradiculon Date: 2012-03-01 Interventions: Biological: IgPro20 |
Completed |
Study Name: Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2011-06-16 |
Withdrawn |
Study Name: High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2010-11-05 Interventions: Drug: Cyclophosphamide |
Terminated |
Study Name: Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2010-10-06 Interventions: Drug: NewGam 10% Loading dose |
Completed |
Study Name: Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2010-08-18 Interventions: Biological: 10% liquid formulation of human immunoglobulin Other Name: IgPro10; Privigen |